Skip to main content
. 2020 Dec;52(4):295–302. doi: 10.1182/ject-2000037

Table 4.

Transfusion requirements during CPB and total intraoperative and postoperative phases.

Matched Cohort (n = 605)
Variable Prescriptive Circuit (n = 204) Conventional Circuit (n = 401) p-Value*
PRBC-CPB (units) .48 (±.97) .51 (±1.14) .6953
FFP-CPB (units) .08 (±.36) .03 (±.22) .0128*
PRBC POST-CPB (units) .66 (±1.75) .77 (±1.72) .9264
FFP POST-CPB (units) .79 (±1.99) .67 (±1.52) .8946
PLT POST-CPB (units) .48 (±1.1) .45 (±.91) .5956
Cryoprecipitate (units) .31 (±.91) .25 (±.76) .6093
Tot. intraoperative PRBC (units) 1.14 (±2.17) 1.28 (±2.35) .9175
Tot. intraoperative FFP (units) .87 (±2.04) .70 (±1.59) .5293
Tot. intraoperative prod. (units) 2.79 (±5.45) 2.68 (±4.92) .3934
PRBC ICU (units) 1.35 (±4.24) 1.48 (±3.99) .1686
FFP-ICU (units) .57 (±2.51) .57 (±2.40) .7112
PLT-ICU (units) .22 (±1.04) .34 (±1.51) .1416
Tot. ICU prod. (units) 3.08 (±3.08) 2.52 (±8.09) .1770

PLT, platelets; POST, post-bypass; tot, total; prod, products.

*

Statistical significance. Data are presented as mean ± SD.